Evidence map›Paper›PMID 33989039›Full record

ReviewThe British journal of radiology2021

MRI features of breast implant-associated anaplastic large cell lymphoma.

Anna Rotili, Federica Ferrari, Luca Nicosia, Filippo Pesapane, Valentina Tabanelli, Stefano Fiori, Anna Vanazzi, Lorenza Meneghetti, Francesca Abbate, Antuono Latronico and 1 more

Open access · bronzeAbstract readReview
In one paragraph

Review in The British journal of radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Imaging of the Reconstructed Breast.Diagnostics (Basel, Switzerland) · 2023
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Anna RotiliDivision of Breast Radiology, IEO - European Institute of Oncology IRCCS, Milan, Italy.
Federica FerrariDivision of Breast Radiology, IEO - European Institute of Oncology IRCCS, Milan, Italy.
Luca NicosiaDivision of Breast Radiology, IEO - European Institute of Oncology IRCCS, Milan, Italy.
Filippo PesapaneDivision of Breast Radiology, IEO - European Institute of Oncology IRCCS, Milan, Italy.
Valentina TabanelliDivision of Diagnostic Hematopathology, IEO - European Institute of Oncology IRCCS, Milan, Italy.
Stefano FioriDivision of Diagnostic Hematopathology, IEO - European Institute of Oncology IRCCS, Milan, Italy.
Anna VanazziDivision of Hemato-Oncology, IEO - European Institute of Oncology IRCCS, Milan, Italy.
Lorenza MeneghettiDivision of Breast Radiology, IEO - European Institute of Oncology IRCCS, Milan, Italy.
Francesca AbbateDivision of Breast Radiology, IEO - European Institute of Oncology IRCCS, Milan, Italy.
Antuono LatronicoDivision of Breast Radiology, IEO - European Institute of Oncology IRCCS, Milan, Italy.
Enrico CassanoDivision of Breast Radiology, IEO - European Institute of Oncology IRCCS, Milan, Italy.
European Institute of Oncology · ITIstituti di Ricovero e Cura a Carattere Scientifico · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare and newly recognized subtype of T cell Non-Hodgkin Lymphoma (NHLs) associated with breast implants.The mechanism involved in the development of this kind of lymphoma is still uncertain.BIA-ALCL is generally an indolent disease localized to the breast implant and its capsule and effectively treated with capsulectomy alone without chemotherapy.Clinically, BIA-ALCL may typically present a sudden-onset breast-swelling secondary to periimplant effusion. The minority of BIA-ALCL patients present a more aggressive mass-forming subtype, for which systemic therapy is mandatory.Despite the number of cases has recently increased, BIA-ALCL remains a rare disease described mainly in several case reports and small case series.Breast imaging, including mammography, ultrasound and breast MRI are routinely used in the screening of breast cancer; however, guidelines for the imaging and pathological diagnosis of this disease have only recently been proposed and included in the 2019 National Comprehensive Cancer Network (NCCN) consensus guidelines for BIA-ALCL.The main purpose of this pictorial is to illustrate the MRI signs of BIA-ALCL and correlate them with the corresponding pathology features in order to improve the knowledge of the principals MRI features of this type of lymphoma.

Indexed as

BreastBreast ImplantsBreast NeoplasmsFemaleHumansLymphoma, Large-Cell, AnaplasticMagnetic Resonance Imaging

Identifiers

PMID33989039
PMCPMC9327767
OpenAlexW3163777888

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.